Latest Dilution News

Harvest Technology Group has raised $500,000 through unsecured convertible notes with a 15% annual interest rate, supporting its strategic three-year profit plan. The notes include attached options exercisable over two years, pending shareholder approval.

Norwood Systems has extended the repayment date on its key loan facility to July 31, 2025, with the principal reduced to $318,341 following significant repayments. This move supports the company’s ongoing growth initiatives, including its recent Optus contract win.

Santana Minerals has unveiled an updated Pre-Feasibility Study for its Bendigo-Ophir Gold Project, revealing lower capital costs, higher gold grades, and robust financial returns that position the project as a low-cost, high-margin operation in New Zealand.

Paradigm Biopharmaceuticals has locked in a $27 million USD convertible note facility to fully fund its pivotal Phase 3 trial for knee osteoarthritis, ensuring operational momentum through key clinical milestones.

Laramide Resources has announced a $10 million private placement to fund critical US permitting and corporate activities, with major shareholder Boss Energy backing the raise.

Many Peaks Minerals Limited has retained its option to acquire 100% of the Baga Gold Project in Côte d’Ivoire, advancing exploration with amended payment terms that blend cash and shares.

Krakatoa Resources Limited has secured an additional $357,000 through a top-up placement, boosting its recent capital raise to $1.659 million. The company also provides a comprehensive update on its Zopkhito Project in Georgia, alongside an extensive review of associated risks.

Domain Holdings Australia Limited is set for acquisition by CoStar Group at $4.43 per share, a premium supported by the Domain Board, Independent Expert, and controlling shareholder Nine. The scheme awaits shareholder and court approval, with a meeting scheduled for August.

Rhythm Biosciences has obtained a $1 million non-dilutive loan backed by its FY2025 R&D Tax Incentive rebate, aiming to accelerate the commercial rollout of its ColoSTAT® test and expand its geneType™ platform.

Duxton Farms has increased its placement to $4.55 million, issuing over 3.6 million new shares to fund the acquisition of four Australian agriculture companies. This move aims to fast-track the company’s diversification and growth strategy in the agricultural investment sector.

Locate Technologies has successfully raised A$320,000 through its At-the-Market Facility, reinforcing its balance sheet as it advances its SaaS delivery platforms Locate2u and Zoom2u.

ClearVue Technologies has secured $746,574 through a mix of equity and debt to support its international commercialisation efforts amid shifting market conditions.